Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


International Stem Cell Corp.

Latest From International Stem Cell Corp.

Deals Shaping the Medical Industry, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.

BioPharmaceutical Medical Device

Financings Of The Fortnight Sees The Blooming Of New Life Sciences Funding Sources In The EU

Plus news on recent financing activity by Aastrom Biosciences, Tarsa Therapeutics, OncoGenex and Medivation.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Metabolic Disorders
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • International Stem Cell Corp.
  • Senior Management
  • Andrey Semechkin, Co-Chmn. & CEO
    Mahnaz Ebrahimi, CPA, CFO
    Russell Kern, PhD, CSO
    Jeremy Hammond, Dir, QC
    Glenn Sherman, Dir, Chemistry Mfg and Controls
  • Contact Info
  • International Stem Cell Corp.
    Phone: (760) 940-6383
    5950 Priestly Drive
    Carlsbad, CA 92008